|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2019
vol. 121 abstract:
Case report
Ophthalmological manifestations in antiphospholid syndrome – case series
Aleksandra Ostrowska-Spaleniak
1
,
Karolina Krix-Jachym
1
,
Marek Rękas
1
Online publish date: 2019/06/05
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The antiphospholipid syndrome is a systemic autoimmune hypercoagulable state, with highly variable symptomatology such as venous and /or arterial thrombosis and obstetric morbidity. Its serological markers are antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and anti-β2-glycoprotein I antibodies. Deep vein thrombosis is the most common complication of antiphospholipid syndrome occurring in about half of patients; thrombotic events may affect many important organs: lungs, skin, brain, liver, kidneys, adrenal glands, heart and eyes. Ocular involvement may occur in about 80% of patients with antiphospholipid syndrome and may be its first clinical manifestation. Retinal arterial and vein occlusion accompanied by various neurological symptoms, such as anterior ischemic optic neuropathy and amaurosis fugax, can be considered as typical of antiphospholipid syndrome. The complications of antiphospholipid syndrome are treated with anticoagulants in order to prevent further thrombotic events.
keywords:
antiphospholipid syndrome, retinal vein occlusion, retinal artery occlusion, anterior ischemic optic neuropathy |
|
POLSKI
